Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Dormant

Current status date:

2021-06-21

Original market date: See footnote 1

2007-10-12

Product name:

MAXIMUM STRENGTH ACID REDUCER

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02298902

Product Monograph/Veterinary Labelling:

Date: 2007-08-24 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

VITA HEALTH PRODUCTS INC
150 Beghin Avenue
Winnipeg
Manitoba
Canada R2J 3W2

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

56:28.12 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A02BA02 RANITIDINE

Active ingredient group (AIG) number:See footnote5

0115150002

List of active ingredient(s)
Active ingredient(s) Strength
RANITIDINE (RANITIDINE HYDROCHLORIDE) 150 MG
Version 4.0.2
Date modified: